Artal Group S.A. - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$2,783,000
+28.8%
750,0000.0%0.04%
+6.1%
Q4 2017$2,160,000
-51.9%
750,000
-25.0%
0.03%
-57.1%
Q3 2017$4,490,0001,000,0000.08%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders